Temozolomide-induced Aplastic Anemia Treated with Eltrombopag and Granulocyte Colony Stimulating Factor: A Report of a Rare Complication

Temozolomide is an alkylating agent used in the treatment for glioblastoma multiforme (GBM), the most frequent primary malignant brain tumor in adults. Temozolomide was approved in March 2005 for treatment of GBM, with the Stupp protocol (radiotherapy and concomitant use of temozolomide). Despite in...

Descripción completa

Detalles Bibliográficos
Autores principales: Newton, Shauna L, Kalamaha, Kadra, Fernandes, Hermina D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248811/
https://www.ncbi.nlm.nih.gov/pubmed/30473962
http://dx.doi.org/10.7759/cureus.3329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248811/
https://www.ncbi.nlm.nih.gov/pubmed/30473962
http://dx.doi.org/10.7759/cureus.3329

Ejemplares similares